Dennis A Ausiello Alnylam Pharmaceuticals, Inc. (ALNY) insider trading activity

Dennis A Ausiello is Director of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 911 shares of ALNY, which is worth approximately $414,532. The most recent transaction as insider was on Aug 14, 2025, when has been sold 31,448 shares (Common Stock) at a price of $437.26 per share, resulting in proceeds of $13,750,952. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 911

0% 3M change

569.85% 12M change

Total Value Held $414,532

Dennis A Ausiello Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 14 2025	SELL Open market or private sale	$13,750,952 $437.26 p/Share	31,448 Reduced 97.18%	911 Common Stock
Aug 14 2025	BUY Exercise of conversion of derivative security	$4,518,763 $143.69 p/Share	31,448 Added 49.29%	32,359 Common Stock
May 08 2025	BUY Grant, award, or other acquisition	-	775 Added 45.97%	911 Common Stock
Aug 06 2024	SELL Open market or private sale	$5,321,497 $262.79 p/Share	20,250 Reduced 99.33%	136 Common Stock
Aug 06 2024	BUY Exercise of conversion of derivative security	$2,394,360 $118.24 p/Share	20,250 Added 49.83%	20,386 Common Stock
Feb 23 2023	BUY Exercise of conversion of derivative security	-	136 Added 50.0%	136 Common Stock
Nov 21 2022	SELL Open market or private sale	$4,950,000 $220.0 p/Share	22,500 Reduced 100.0%	0 Common Stock
Nov 21 2022	BUY Exercise of conversion of derivative security	$1,599,525 $71.09 p/Share	22,500 Added 50.0%	22,500 Common Stock

Also insider at

PFE

PFIZER INC Healthcare

Director

MCRB

Seres Therapeutics, Inc. Healthcare

RANI

Rani Therapeutics Holdings, Inc. Healthcare

DAA